>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance: EEI +14.6%, BOBE +4.7%, ITI +1.1%

M&A news: QIHU +9.1% (receives non-binding proposal to be acquired for $77/share by group including its Chairman and CEO), TMUS +2.3% (Deutsche Telecom (DTEGY) is working with Comcast (CMCSA) on T Mobile sale, according to Manager-Magazine)

Select China related names showing strength: SHI +5.3%, SFUN +4.6%, CO +4.4%, DANG +2.5%, KNDI +2.4%

Select oil/gas related names showing strength: SD +1.8%, RIG +1.3%, CHK +0.9%, STO +0.8%, COP +0.6%, VLO +0.5%

Other news: SGYP +53.4% (announces positive results in its first Phase 3 trial of Plecanatide to treat chronic idiopathic constipation), KYTH +22.4% (to be acquired by Allergan (AGN) for $75 per share), TRCH +14.3% (signs LOI for portion of Hunton assets), FREE +9.9% (cont strength), MANU +9.2% (Ron Baron spoke favorably on CNBC; continues to like),MDXG +5% (CEO interview on CNBC who discussed that the co's amniotic membrane tissue may help wounds heal faster), ARWR +3.1% (receives regulatory clearance in Germany to begin additional phase 2b studies of HBV candidate ARC-520), RLH +2.8% (HNA Group acquired ~3 mln shares of RLH's common stock), directly from Columbia Pacific), JAKK+2.3% (still checking), ANTH +2.1% (announced that it has met the enrollment target of its CHABLIS-SC1 Phase 3 clinical trial evaluating blisibimod for the treatment of lupus. Final data from the trial is expected in the second half of 2016), ERN +2.1% (issues response to allegations raised in an article authored by Cannell Capital), SDRL +2% (sells ultra-deepwater drillship the West Polaris to Seadrill Partners), DOW +1.6% (still checking), MBLY +1.6% (Ron Baron spoke favorably on CNBC; continues to like), CELG +1.3% (announces additional $4 billion share repurchase authorization), TASR +1% (announces new orders for its smart weapons), FFIC +0.9% (announced authorization of 1 mln share stock repurchase program)

Analyst comments: HIMX +4.1% (target raised to $11 from $9 at Northland Capital), MXWL +3.5% (upgraded to Outperform from Market Perform at Northland ), WLL +2.3% (upgraded to Buy from Neutral at Citigroup), STR +1.1% (upgraded to Buy from Hold at Jefferies), CRR +1.1% (upgraded to Sector Perform from Underperform at Iberia), RSTI +1% (initiated with a Buy at The Benchmark Company ), ADPT +0.9% (Adeptus Health target raised to $102 from $69 at Piper Jaffray), BTI +0.7% (upgraded to Neutral from Sell at Goldman), FB +0.7% (target raised to $108 at Brean Capital
)

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance: DTEA -13.2%, LZB -4.1%, NR -3.5%, ( provides operational update: Seen a modest reduction in Fluids Systems revenues since May, driven by continued slide in U.S. rig counts and weather-related delays), ADBE -1.5%, FDX -1.1%

Select EU related names showing weakness: NVO -1.8%, ALU -1.6%, SNY -1.4%, ASML -1.3%, UN -1.1%, PHG -0.8%, NOK -0.6%

Other news: RCPI -15.2% (announces $3.7 mln registered direct offering at purchase price of $2.25/unit), AZUR -10.7% (announces public offering), OCAT -9% (prices $30 mln offering of common stock and warrants), NR -3.5% (provided operational update: seen a modest reduction in Fluids Systems revenues since May, driven by continued slide in U.S. rig counts and weather-related delay), EGN -2.6% (announced that over the past week, it has entered into swap contracts for approximately 1.1 million barrels of 2016 oil production at an average NYMEX price of $63.80 per barrel), ARNA -2.3% (announces that CFO Robert Hoffman has decided to leave the company to pursue another opportunity in the biotechnology industry),VEC -0.9% (disclosed that Theodore R. Wright, EVP and Chief Operating Officer will retire effective June 30, 2015), ADES -0.5% (provided accounting update; appointed A. Bradley Gabbard as CFO)

Analyst comments: RTEC -2% (downgraded to Mkt Perform from Outperform at Barrington Research), COTY -1.8% (downgraded to Neutral from Buy at Citigroup), ZIXI -1.5% (downgraded to Hold from Buy at Craig Hallum), DX -1.5% (downgraded to Underperform from Neutral at BofA/Merrill), BMY -1.3% (initiated with a Underweight at Piper Jaffray
)